Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Astria Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 43 | 61 | +18 |
| Shares | 9.83M | 22.0M | +12.1M (+123.5%) |
| Value | $88.8M | $326.1M | +$237.2M (+267.0%) |
New holders (23)
Institutions that held Astria Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (5)
Institutions that held Astria Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Alyeska Investment Group, L.P. | 274,719 | $2.48M |
| Artal Group S.A. | 33,333 | $301.0K |
| Botty Investors LLC | 24,331 | $220.0K |
| JPMorgan Chase & Co | 299 | $3.00K |
| BNP Paribas Arbitrage, SA | 119 | $1.08K |